Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Quris AI logo — Leading the AI-Pharma Revolution

Quris AI

Leading the AI-Pharma Revolution

Founded 2019 United States Boston, United States 33 employees Seed Total: $37.00M AI, Biotechnology +3

General Information

Company Name Quris AI
Founded Year 2019
Location United States Boston, United States
Employees 33
Industries AI, Biotechnology, Health Care +2
Funding Stage Seed
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Licensing, Service Fee
Offices as of Sep 2026
Boston, United States
Social

BounceWatch is an independent company data service, not affiliated with Quris AI. To contact Quris AI, visit quris.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Quris AI compare?

A PDF of Quris AI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Quris AI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Quris AI

Quris AI, founded in 2019, is at the forefront of the AI-Pharma Revolution with its cutting-edge artificial intelligence technologies aimed at reshaping drug development. The company, headquartered in the United States, is making waves in the AI, Biotechnology, Health Care, Pharmaceutical, and Robotics industries.

At the heart of Quris AI's innovation is a machine-learning bio-platform designed to enhance the accuracy of predicting drug candidates that will safely function in humans, thereby circumventing the monumental expenses tied to failed clinical trials. This platform's promise is upheld by a robust team of top-tier scientists supported by strategic investors, allowing the company to position its first AI-based drug for upcoming clinical testing.

The company secured a $9.00M Seed Round investment on 20 December 2022, backed by prominent players such as iAngels, SoftBank Vision Fund, Welltech Ventures, Richter Group, and GlenRock Israel. This investment underlines the confidence investors have in Quris AI's transformative potential in the pharmaceutical domain.

Business keywords: AI-Pharma, Drug Development, Bio-Platform, Clinical Safety Prediction, Efficacy Prediction, Clinical Testing, Automated AI Platform, Cost-effective Drug Development, Minimizing Animal Testing, Failed Clinical Trial Reduction, AI-Based Drug

Services & Products

AI-driven drug safety platforms
Machine Learning model training
Testing drugs with Patients-on-a-Chip technology
Reducing clinical trial failures

Target Customers

Pharmaceutical companies Biotechnology firms Clinical researchers Healthcare institutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $9.00M 5
iAngels SoftBank Vision Fund Welltech Ventures
iAngels, SoftBank Vision Fund +3
20 Dec 2022
Seed Round $19.00M 3
iAngels Welltech Ventures
iAngels, Welltech Ventures +1
11 Jan 2022
Seed Round $9.00M 2
Fusion LA
Fusion LA, Moshe Yanai
18 Oct 2021

Quris AI Alternatives & Competitors

View All Alternatives
Quris AI vs
AsedaSciences®
AsedaSciences® Switzerland

Helping scientists develop safer chemicals

11 employees
Biotechnology, Life Sciences
Compare Quris AI vs AsedaSciences®
Quris AI vs
Ignota Labs
Ignota Labs United Kingdom

Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hop...

Seed
18 employees
AI, Biotechnology
Compare Quris AI vs Ignota Labs
Quris AI vs
Partex.AI Technology
Partex.AI Technology India

The experts in AI technology for drug discovery and development.

Series C
182 employees
AI, Analytics
Also compare with: Quris AI vs VeriSIM Life VeriSIM Life View all alternatives

FAQ About Quris AI

Leading the AI-Pharma Revolution
Quris AI was founded in 2019.
Quris AI is headquartered in Boston, United States.
Quris AI operates in AI, Biotechnology, Health Care, Pharmaceutical and Robotics. Its work centres on AI-Pharma, Drug Development, Bio-Platform and Clinical Safety Prediction. Its customers include Pharmaceutical companies, Biotechnology firms and Clinical researchers.
Quris AI has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Licensing and Service Fee.
Quris AI has approximately 33 employees.
Quris AI has completed 3 funding rounds, raising a total of $37.00M. The latest funding stage is Seed.
Quris AI offers: AI-driven drug safety platforms, Machine Learning model training, Testing drugs with Patients-on-a-Chip technology, Reducing clinical trial failures.
Top alternatives and competitors to Quris AI include AsedaSciences®, Ignota Labs, Partex.AI Technology, ONCOCROSS Co., Ltd., InterAx Biotech Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quris AI and AsedaSciences® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Quris AI, https://bouncewatch.com/company/quris-ai, updated 21 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout